期刊文献+

急性冠脉综合征患者PCI术后血管并发症发生情况及其影响因素分析 被引量:9

Occurrence of vascular complications and its influencing factors in patients with acute coronary syndrome after PCI
原文传递
导出
摘要 目的:分析急性冠脉综合征(ACS)患者经皮冠状动脉介入术(PCI)后血管并发症发生情况及其影响因素。方法:选取2018年2月~2020年5月医院心血管内科行PCI手术的ACS患者496例为研究对象,依据术后3个月是否发生血管并发症将其分为观察组(n=124,术后3个月发生血管并发症)、 对照组(n=372,术后3个月未发生血管并发症),对比两组临床资料,分析血管并发症的影响因素。结果:本研究中共124例ACS患者在PCI术后发生血管并发症(25.00%),其中以桡动脉痉挛、局部出血、局部血肿、上肢肿胀及疼痛较常见,发生率分别为11.90%、6.65%、5.85%;单因素及多因素Logistic回归分析显示,年龄、病程、急诊PCI、手术持续时间、抗凝药物使用不当、手术部位管理不规范是ACS患者PCI术后发生血管并发症的危险因素,而经桡动脉途径入路、规范的手术期患者管理、规律服药、健康宣教是其保护因素。结论:ACS患者易受年龄、病程、急诊PCI、手术持续时间、抗凝药物使用不当、手术部位管理不规范而在PCI术后发生血管并发症,采用经桡动脉途径入路、合理使用抗凝药物、规律服药及规范的手术期患者管理、健康宣教可减少血管并发症发生。 Objective To analyze the occurrence of vascular complications and its influencing factors in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI).Methods A total of 496 patients with ACS who underwent PCI in the Hospital from February 2018 to May 2020 were selected for the study and were divided into observation group (n=124,vascular complications at 3 months after operation) and control group (n=372,no vascular complications at 3 months after operation) according to whether there were vascular complications at 3 months after operation or not.The clinical data of the two groups were compared,and the influencing factors for vascular complications were analyzed.Results 124 patients with ACS had vascular complications after PCI (25.00%).Among complications,local bleeding,local hematoma,upper extremity swelling and pain were more common with incidence rates of 11.90%、6.65%、5.85% respectively.Univariate and multivariate Logistic regression analysis showed that age,disease duration,emergency PCI,operative time,improper use of anticoagulant drugs,irregular management of surgical sites were risk factors for vascular complications in patients with ACS after PCI,and transradial approach,regular medication,standardized surgical management,and health education were the protective factors.Conclusions Patients with ACS are susceptible to vascular complications after PCI due to age,disease duration,emergency PCI and operative time.The use of trans-radial approach,rational use of anticoagulant drugs,regular medication and standardized surgical management,health education can reduce vascular complications.
作者 郭莉 张雪梅 Guo Li;Zhang Xue-mei(Department of Critical Care Medicine,Bazhong Central Hospital,Bctzhong 636000,China;Department of Cardiology,Bazhong Central Hospital,Bazhong 636000,China)
出处 《湖南师范大学学报(医学版)》 2022年第1期183-186,共4页 Journal of Hunan Normal University(Medical Sciences)
关键词 急性冠脉综合征 PCI 血管 并发症 影响因素 acute coronary syndrome PCI vascular complications influencing factors
  • 相关文献

参考文献10

二级参考文献92

  • 1王枫岭,解金红,司荣圣,刘志远.急诊PCI抢救急性心肌梗死在基层医院的扩展性分析[J].中国心血管病研究,2005,3(6):419-422. 被引量:15
  • 2罗静,王瑞红,丁金玲.循证护理在冠心病介入手术患者健康教育中的应用[J].现代护理,2005,11(23):2016-2017. 被引量:8
  • 3Tantry US,Bliden KP,Gurhel PA. Resistance to antiplatelet drugs= Current status and future resezreh[J]. Expert Opin Pharmacother, 2005,6 (12): 2027 - 2045.
  • 4Gurhel PA, Bliden KP, Hayes KM,et al. Platelet activation in myocar dial isehemic syndromes[J]. Expert Rev Cardiovasc Ther, 2004,2 (4) :535- 545.
  • 5Gurhel PA, Bliden KP, Zaman KA, et al. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets:Results of the Clo- pidogrel Loading with Eptifibatide to Arrest the Reactivity of Platelets(CLEAR PLATEI. ETS) study[J]. Circulation, 2005,111 (9) :1153 - 1159.
  • 6Gurbel PA, Bliden KP, Samara W, et al. Clopidogre] effect on platelet reactivity in patients with stent thrombosis:Results of the CREST Study[J]. J Am Coil Cardiol,2005,46(10) :1827 - 1832.
  • 7Amabile N, Hammas S, Fradi S, et al. Intra-coronary thrombus evolu- tion during acute coronary syndrome : Regression assessment by serial optical coherence tomography analyses [ J ]. Annales de Cardiologie et d'Ang6iologie,2013 ,62(12) :374-375.
  • 8Swahn E, Alfredsson J. Invasive Treatment of non-st-segment eleva- tion acute coronary syndrome: cardiac catheterization/revasculariza- tion for all[ J]. Revista Espafiola de Cardiologia (English Edition), 2014,67 ( 3 ) :218-221.
  • 9Cannon CP,Brindis RG,Chaitman BR,et al. 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease : a report of the American College of Cardiology Foun- dation/American Heart Association Task Force on clinical data standards (writing committee to develop acute coronary syndromes and coronary artery disease clinical data standards) [ J]. Journal of the American College of Cardiology,2013,61 (9) :992-1025.
  • 10Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992 [ J ]. Ja- ma,2000,283 (18) :2404-2410.

共引文献133

同被引文献100

引证文献9

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部